The North America Enteral Nutrition Market is poised for substantial growth from 2020 to 2030, fueled by progress in medical nutrition, an older population, and a rising prevalence of chronic diseases that require specialized nutritional assistance. Enteral nutrition, which provides nutrients directly to the gastrointestinal tract through feeding tubes, is an essential aspect of managing patients who cannot fulfill their nutritional needs through normal oral intake because of conditions like stroke, traumatic injuries, cancer, and gastrointestinal issues. The market is undergoing significant growth as healthcare providers increasingly acknowledge the clinical advantages of early nutritional intervention in enhancing patient outcomes, minimizing hospital stays, and decreasing healthcare expenses. Technological advancements in formulation, delivery systems, and packaging have also aided market growth by improving product safety, administration ease, and patient adherence. Manufacturers are allocating resources to research and development to produce advanced enteral formulas customized to meet the specific nutritional requirements of different patient groups, including those with metabolic disorders, renal failure, or immune deficiencies. The increasing prevalence of obesity and related issues such as type 2 diabetes has escalated the demand for specialized enteral nutrition products that assist in weight management and metabolic regulation.
North America enteral nutrition market is expected to grow by 7.8% annually in the forecast period and reach $5,873.8 million by 2030. Regulatory agencies in North America, especially the U. S. Food and Drug Administration (FDA) and Health Canada, have implemented stringent regulations to ensure the quality and effectiveness of enteral nutrition products, which has consequently enhanced consumer and provider trust in these therapies. Moreover, the growth of home healthcare services and longterm care facilities has opened new avenues for market participants, as more patients are receiving enteral nutrition outside typical hospital environments. The incorporation of digital health technologies, like remote monitoring and telehealth platforms, is also transforming the market by allowing healthcare professionals to monitor patient progress and modify nutritional therapies in realtime. Consequently, both established multinational corporations and emerging local entities are actively broadening their product offerings and distribution channels to seize a larger segment of the expanding market. Strategic partnerships and collaborations among manufacturers, healthcare providers, and research institutions are further promoting innovation, resulting in the creation of nextgeneration enteral nutrition solutions that provide better bioavailability, targeted nutrient delivery, and greater patient acceptance. Overall, the North America Enteral Nutrition Market is on a growth path, supported by advantageous demographic trends, technological progress, and a strong commitment to enhancing patient care, which together position the market for continued growth and innovation through 2030.
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Critical Care applications generate significant income due to the intensive nutritional requirements of patients in severe conditions, whereas the Diabetes segment concentrates on specialized formulations for metabolic management. Neurology and Oncology applications serve patients with complex, specific condition needs, which increases the demand for tailored nutritional support. Other Applications encompass additional therapeutic areas, responding to various clinical challenges. This segmentation highlights the market’s adaptability to different patient requirements and changing clinical practices, fostering targeted innovation and revenue growth. Enteral Nutrition for Chronic Illness meets the specialized needs of patients with longterm health conditions, providing tailored nutrients to enhance clinical outcomes and overall quality of life. Conversely, Enteral Nutrition with Standard Formula delivers a more general nutritional solution that is suitable for a wider patient population, guaranteeing consistent, costeffective support in routine care. This categorization illustrates the varied clinical needs and strategic pricing models that propel market growth. The North America enteral nutrition market is structured by product form into Liquid Enteral Nutrition and Powder Enteral Nutrition, with annual revenue ($ mn) statistics provided for 20192030.
Liquid Enteral Nutrition is preferred for its ease of administration, quick absorption, and suitability for patients with compromised digestion, whereas Powder Enteral Nutrition presents benefits in storage, preparation flexibility, and costefficiency. Pediatric formulations are designed for children with specific nutritional requirements, ensuring safe and efficient growth support. The adult segment aims at delivering comprehensive nutrition for individuals with chronic illnesses and recovery after surgery, whereas the geriatric segment tackles agerelated nutritional issues, like decreased appetite and impaired digestion. Each segment showcases specific product formulations and clinical advantages, facilitating revenue growth as healthcare providers enhance nutritional support during various life stages globally both today and consistently. Hospital distribution channels predominantly cater to inpatient environments, guaranteeing prompt access to enteral nutrition products for critical and acute care patients. Retail pharmacies address outpatient requirements by offering nutritional formulations for chronic conditions, while online pharmacies are expanding due to the convenience and digital ordering systems. Every channel is essential in broadening market access, improving patient availability, and promoting overall revenue growth throughout the region.
Considered in this report
• Historic Year: 2019
• Base year: 2024
• Estimated year: 2025
• Forecast year: 2030
Make this report your own
Have queries/questions regarding a report
Take advantage of intelligence tailored to your business objective
Sikandar Kesari
Research Analyst
Aspects covered in this report
• North America Enteral Nutrition Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation
Based on Nutrient, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Protein Based Nutrition
• Standard Protein Diet
• High Protein Supplement
• Protein for Diabetic Patients
• Other Protein-based Nutitions
• Carbohydrates Based Nutrition
• Fat Based Nutrition
• Vitamin Based Nutrition
• Other Nutrition Types
Based on Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Critical Care
• Diabetes
• Neurology
• Oncology
• Other Applications
Don’t pay for what you don’t need. Save 30%
Customise your report by selecting specific countries or regions
Based on Category, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Enteral Nutrition for Chronic Illness
• Enteral Nutrition with Standard Formula
Based on Product Form, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Liquid Enteral Nutrition
• Powder Enteral Nutrition
Based on End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Pediatric
• Adults
• Geriatric
Based on Distribution Channel, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Distribution by Hospitals
• Distribution by Retail Pharmacies
• Distribution by Online Pharmacies
The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and listing out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, annual report of companies, analyzing the government generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducted trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers in regional aspects, tier aspects, age group, and gender. Once we have primary data with us we have started verifying the details obtained from secondary sources.
Intended audience
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to agriculture industry, government bodies and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.
Table of Contents
Table of Contents
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 26
2.3 Market Restraints and Challenges 29
2.4 Emerging Opportunities and Market Trends 32
2.5 Porter’s Fiver Forces Analysis 36
3 Segmentation of North America Market by Nutrient 40
3.1 Market Overview by Nutrient 40
3.2 Protein Based Nutrition 42
3.2.1 Standard Protein Diet 44
3.2.2 High Protein Supplement 45
3.2.3 Protein for Diabetic Patients 46
3.2.4 Other Protein-based Nutitions 47
3.3 Carbohydrates Based Nutrition 48
3.4 Fat Based Nutrition 49
3.5 Vitamin Based Nutrition 50
3.6 Other Nutrition Types 51
4 Segmentation of North America Market by Application 52
4.1 Market Overview by Application 52
4.2 Critical Care 54
4.3 Diabetes 55
4.4 Neurology 56
4.5 Oncology 57
4.6 Other Applications 58
5 Segmentation of North America Market by Category 60
5.1 Market Overview by Category 60
5.2 Enteral Nutrition for Chronic Illness 62
5.3 Enteral Nutrition with Standard Formula 63
6 Segmentation of North America Market by Product Form 64
6.1 Market Overview by Product Form 64
6.2 Liquid Enteral Nutrition 66
6.3 Powder Enteral Nutrition 67
7 Segmentation of North America Market by End User 68
7.1 Market Overview by End User 68
7.2 Pediatric 70
7.3 Adults 71
7.4 Geriatric 72
8 Segmentation of North America Market by Distribution Channel 73
8.1 Market Overview by Distribution Channel 73
8.2 Distribution by Hospitals 75
8.3 Distribution by Retail Pharmacies 76
8.4 Distribution by Online Pharmacies 77
9 North America Market 2019-2030 by Country 78
9.1 Overview of North America Market 78
9.2 U.S. 81
9.3 Canada 85
9.4 Mexico 87
10 Competitive Landscape 89
10.1 Overview of Key Vendors 89
10.2 New Product Launch, Partnership, Investment, and M&A 92
10.3 Company Profiles 93
Abbott Laboratories 93
B. Braun Melsungen AG 95
Baxter International, Inc. 96
Danone S.A. 97
Fresenius Kabi AG 98
North America Health Products, Inc. 99
Hormel Foods Corporation 100
Mead Johnson Nutrition Company 101
Meiji Holdings Co., Ltd. 102
Nestle S.A. 103
Reckitt Benckiser Group LLC 104
Victus, Inc. 105
11 Investing in North America Market: Risk Assessment and Management 106
11.1 Risk Evaluation of North America Market 106
11.2 Critical Success Factors (CSFs) 109
Related Reports and Products 112
Table 1. Snapshot of North America Enteral Nutrition Market, 2019-2030 18
Table 2. Growth Rate of World Real GDP, 2017-2021 22
Table 3. Main Product Trends and Market Opportunities in North America Enteral Nutrition Market 32
Table 4. North America Enteral Nutrition Market by Nutrient, 2019-2030, $ mn 40
Table 5. North America Enteral Nutrition Market: Protein Based Nutrition by Type, 2019-2030, $ mn 43
Table 6. North America Enteral Nutrition Market by Application, 2019-2030, $ mn 52
Table 7. North America Enteral Nutrition Market by Category, 2019-2030, $ mn 60
Table 8. North America Enteral Nutrition Market by Product Form, 2019-2030, $ mn 64
Table 9. North America Enteral Nutrition Market by End User, 2019-2030, $ mn 68
Table 10. North America Enteral Nutrition Market by Distribution Channel, 2019-2030, $ mn 73
Table 11. North America Enteral Nutrition Market by Country, 2019-2030, $ mn 79
Table 12. U.S. Enteral Nutrition Market by Nutrient, 2019-2030, $ mn 83
Table 13. U.S. Enteral Nutrition Market by Application, 2019-2030, $ mn 83
Table 14. U.S. Enteral Nutrition Market by End User, 2019-2030, $ mn 83
Table 15. Canada Enteral Nutrition Market by Nutrient, 2019-2030, $ mn 86
Table 16. Canada Enteral Nutrition Market by Application, 2019-2030, $ mn 86
Table 17. Canada Enteral Nutrition Market by End User, 2019-2030, $ mn 86
Table 18. Mexico Enteral Nutrition Market by Nutrient, 2019-2030, $ mn 88
Table 19. Mexico Enteral Nutrition Market by Application, 2019-2030, $ mn 88
Table 20. Mexico Enteral Nutrition Market by End User, 2019-2030, $ mn 88
Table 21. Abbott Laboratories: Company Snapshot 93
Table 22. Abbott Laboratories: Business Segmentation 93
Table 23. Abbott Laboratories: Product Portfolio 94
Table 24. Abbott Laboratories: Revenue, 2016-2018, $ mn 94
Table 25. Abbott Laboratories: Recent Developments 94
Table 26. Risk Evaluation for Investing in North America Market, 2019-2030 107
Table 27. Critical Success Factors and Key Takeaways 110
Figure 1. Research Method Flow Chart 11
Figure 2. Breakdown of Primary Research 13
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 4. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 17
Figure 5. North America Enteral Nutrition Market, 2019-2030, $ mn 20
Figure 6. Impact of COVID-19 on Business 24
Figure 7. Primary Drivers and Impact Factors of North America Enteral Nutrition Market 26
Figure 8. Primary Restraints and Impact Factors of North America Enteral Nutrition Market 29
Figure 9. Investment Opportunity Analysis 33
Figure 10. Porter’s Fiver Forces Analysis of North America Enteral Nutrition Market 36
Figure 11. Breakdown of North America Enteral Nutrition Market by Nutrient, 2019-2030, % of Revenue 41
Figure 12. North America Addressable Market Cap in 2020-2030 by Nutrient, Value ($ mn) and Share (%) 41
Figure 13. North America Enteral Nutrition Market: Protein Based Nutrition, 2019-2030, $ mn 42
Figure 14. North America Enteral Nutrition Market: Standard Protein Diet, 2019-2030, $ mn 44
Figure 15. North America Enteral Nutrition Market: High Protein Supplement, 2019-2030, $ mn 45
Figure 16. North America Enteral Nutrition Market: Protein for Diabetic Patients, 2019-2030, $ mn 46
Figure 17. North America Enteral Nutrition Market: Other Protein-based Nutitions, 2019-2030, $ mn 47
Figure 18. North America Enteral Nutrition Market: Carbohydrates Based Nutrition, 2019-2030, $ mn 48
Figure 19. North America Enteral Nutrition Market: Fat Based Nutrition, 2019-2030, $ mn 49
Figure 20. North America Enteral Nutrition Market: Vitamin Based Nutrition, 2019-2030, $ mn 50
Figure 21. North America Enteral Nutrition Market: Other Nutrition Types, 2019-2030, $ mn 51
Figure 22. Breakdown of North America Enteral Nutrition Market by Application, 2019-2030, % of Sales Revenue 53
Figure 23. North America Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%) 53
Figure 24. North America Enteral Nutrition Market: Critical Care, 2019-2030, $ mn 54
Figure 25. North America Enteral Nutrition Market: Diabetes, 2019-2030, $ mn 55
Figure 26. North America Enteral Nutrition Market: Neurology, 2019-2030, $ mn 56
Figure 27. North America Enteral Nutrition Market: Oncology, 2019-2030, $ mn 57
Figure 28. North America Enteral Nutrition Market: Other Applications, 2019-2030, $ mn 58
Figure 29. Breakdown of North America Enteral Nutrition Market by Category, 2019-2030, % of Sales Revenue 61
Figure 30. North America Addressable Market Cap in 2020-2030 by Category, Value ($ mn) and Share (%) 61
Figure 31. North America Enteral Nutrition Market: Enteral Nutrition for Chronic Illness, 2019-2030, $ mn 62
Figure 32. North America Enteral Nutrition Market: Enteral Nutrition with Standard Formula, 2019-2030, $ mn 63
Figure 33. Breakdown of North America Enteral Nutrition Market by Product Form, 2019-2030, % of Revenue 65
Figure 34. North America Addressable Market Cap in 2020-2030 by Product Form, Value ($ mn) and Share (%) 65
Figure 35. North America Enteral Nutrition Market: Liquid Enteral Nutrition, 2019-2030, $ mn 66
Figure 36. North America Enteral Nutrition Market: Powder Enteral Nutrition, 2019-2030, $ mn 67
Figure 37. Breakdown of North America Enteral Nutrition Market by End User, 2019-2030, % of Revenue 69
Figure 38. North America Addressable Market Cap in 2020-2030 by End User, Value ($ mn) and Share (%) 69
Figure 39. North America Enteral Nutrition Market: Pediatric, 2019-2030, $ mn 70
Figure 40. North America Enteral Nutrition Market: Adults, 2019-2030, $ mn 71
Figure 41. North America Enteral Nutrition Market: Geriatric, 2019-2030, $ mn 72
Figure 42. Breakdown of North America Enteral Nutrition Market by Distribution Channel, 2019-2030, % of Revenue 73
Figure 43. North America Addressable Market Cap in 2020-2030 by Distribution Channel, Value ($ mn) and Share (%) 74
Figure 44. North America Enteral Nutrition Market: Distribution by Hospitals, 2019-2030, $ mn 75
Figure 45. North America Enteral Nutrition Market: Distribution by Retail Pharmacies, 2019-2030, $ mn 76
Figure 46. North America Enteral Nutrition Market: Distribution by Online Pharmacies, 2019-2030, $ mn 77
Figure 47. Breakdown of North America Enteral Nutrition Market by Country, 2019 and 2030, % of Revenue 79
Figure 48. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 80
Figure 49. U.S. Enteral Nutrition Market, 2019-2030, $ mn 82
Figure 50. Canada Enteral Nutrition Market, 2019-2030, $ mn 85
Figure 51. Enteral Nutrition Market in Mexico, 2015-2030, $ mn 87
Figure 52. Growth Stage of North America Enteral Nutrition Industry over the Forecast Period 89
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information